Logo
Login
$APRE
$0.51 +$0.06 (14.25%) Close

Company Executives

$APRE Management Team

Dr. Jean-Pierre Bizzari

Independent

Age 70
Compensation $44.00K USD
Sex Male

Dr. Richard Peters

Independent Chairman of the Board

Age 62
Compensation $97.43K USD
Sex Male

Dr. Oren Gilad

President

Chief Executive Officer

Director

Age 56
Compensation $760.1K USD
Sex Male

Mr. John Hamill

Chief Financial Officer

Senior Vice President

Secretary

Age 61
Compensation $536.6K USD
Sex Male

Dr. Nadeem Mirza

Chief Medical Officer

Age -
Compensation $447.7K USD
Sex Male

Board of Directors

From the proxy statement filed Apr 30, 2026
Directors
9
serving now
Independent
8 of 9
stated in the proxy
Average tenure
5.1 years
from year joined
CEO also chairs the board
No
Richard Peters, M.D., Ph.D.
Director Age On board Independent Committees Other public boards Pay Source
Marc Duey
70 2022
4 years
 Independent
Compensation
None stated Not stated
Richard Peters, M.D., Ph.D.
Board chair
 63 2020
6 years
 Independent
Compensation · Chair
Kineta, Inc., Pharming Group N.V. Not stated
Bernd R. Seizinger, M.D., Ph.D.
69 2015
11 years
 Independent
Nominating and Corporate Governance Audit
Aptose Biosciences Inc., Oncolytics Biotech Inc., BioInvent International AB Not stated
Michael Grissinger
72 2022
4 years
 Independent
Nominating and Corporate Governance · Chair Audit
None stated Not stated
Gabriela Gruia, M.D.
69 2023
3 years
 Independent None stated TSCAN Therapeutics, Inc. Not stated
Rifat Pamukcu, M.D.
68 2022
4 years
 Independent
Compensation Nominating and Corporate Governance
None stated Not stated
Jean-Pierre Bizzari, M.D.
71 2023
3 years
 Independent None stated ADC Therapeutics SA Not stated
Oren Gilad, Ph.D.
CEO
 57 2022
4 years
 Not independent None stated None stated Paid as CEO
John B. Henneman III
64 2019
7 years
 Independent
Audit · Chair Nominating and Corporate Governance
Orthofix Medical, Inc., Anika Therapeutics, Inc. Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

No related-party transactions disclosed

The proxy filed Apr 30, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans